Worm D, Vinten J, Staehr P, Henriksen J E, Handberg A, Beck-Nielsen H
Diabetes Research Centre, Odense University Hospital, Denmark.
Diabetologia. 1996 Oct;39(10):1208-14. doi: 10.1007/BF02658508.
To measure possible changes in basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from insulin-resistant individuals, soluble and particulate muscle fractions were prepared from biopsies taken before and after a 3-h hyperinsulinaemic euglycaemic clamp in eight non-insulin-dependent diabetic (NIDDM) patients and nine control subjects. We used a sensitive sandwich-immunofluorescence assay and the human insulin receptor as the substrate. PTPase activity was expressed as percentage of dephosphorylation of phosphotyrosyl-residues in immobilized insulin receptors per 2 h incubation time per 83 micrograms and 19 micrograms muscle fraction protein (soluble and particulate fraction, respectively). In the diabetic soluble muscle fractions, the basal PTPase activity was decreased compared with that of control subjects (11.5 +/- 5.5 vs 27.5 +/- 3.3, p < 0.04, mean +/- SEM). In the particulate muscle fractions from the control subjects, PTPase activity was increased after 3 h hyperinsulinaemia (20.0 +/- 3.2 vs 30.2 +/- 3.6, p < 0.03) and in the corresponding soluble fractions PTPase activity seemed decreased (27.5 +/- 3.3 vs 19.9 +/- 5.9, NS). No effect of insulin on PTPase activity was found in NIDDM patients (25.1 +/- 4.1 vs 27.2 +/- 5.2, 11.5 +/- 5.5 vs 15.1 +/- 4.5 [particulate and soluble fractions], NS). In conclusion, we found that the basal PTPase activity in soluble muscle fractions was decreased in NIDDM patients; furthermore, insulin stimulation was unable to increase PTPase activities in the particulate fractions, as opposed to the effect of insulin in control subjects.
为了测定胰岛素抵抗个体骨骼肌中基础和胰岛素刺激的磷酸酪氨酸磷酸酶(PTPase)活性的可能变化,在8名非胰岛素依赖型糖尿病(NIDDM)患者和9名对照受试者进行3小时高胰岛素正常血糖钳夹前后,从活检组织中制备了可溶性和颗粒性肌肉组分。我们使用了一种灵敏的夹心免疫荧光测定法,并以人胰岛素受体作为底物。PTPase活性表示为每2小时孵育时间内,每83微克和19微克肌肉组分蛋白(分别为可溶性和颗粒性组分)中固定化胰岛素受体上磷酸酪氨酸残基去磷酸化的百分比。在糖尿病患者的可溶性肌肉组分中,基础PTPase活性与对照受试者相比降低(11.5±5.5对27.5±3.3,p<0.04,平均值±标准误)。在对照受试者的颗粒性肌肉组分中,高胰岛素血症3小时后PTPase活性增加(20.0±3.2对30.2±3.6,p<0.03),而在相应的可溶性组分中PTPase活性似乎降低(27.5±3.3对19.9±5.9,无显著性差异)。在NIDDM患者中未发现胰岛素对PTPase活性有影响(25.1±4.1对27.2±5.2,11.5±5.5对15.1±4.5[颗粒性和可溶性组分],无显著性差异)。总之,我们发现NIDDM患者可溶性肌肉组分中的基础PTPase活性降低;此外,与对照受试者中胰岛素的作用相反,胰岛素刺激无法增加颗粒性组分中的PTPase活性。